My Dog's $1,500 Cough: What Pet Healthcare Taught Me About Broken Markets

---

A few weeks ago, my dog developed a frightening combination of symptoms: bloody stool, vomiting, and a persistent dry cough.

Like most pet owners, I panicked.

I rushed her to a local veterinary clinic. The consultation quickly escalated into X-rays, blood tests, and a series of diagnostic procedures. The bill came to roughly $800. The diagnosis was tentative—possibly food poisoning—and we were sent home with a small pharmacy's worth of medication: anti-nausea drugs, probiotics, pain relief, stool firmers, and deworming treatment.

One thing stood out.

The veterinarian specifically said antibiotics were unnecessary.

The symptoms persisted.

The next day, I visited a second clinic. After another consultation and additional testing, the diagnosis shifted toward gastroenteritis. The bill increased by another $700.

Their advice?

Stop every medication prescribed by the first clinic and begin a course of antibiotics immediately.

At this point, I had spent $1,500, accumulated two conflicting medical opinions, and my dog was still coughing.

A friend eventually suggested a Chinese telehealth platform called Mogu Pet Doctor.

Skeptical but desperate, I booked a video consultation.

The veterinarian listened carefully, reviewed the symptoms, and suggested that the gastrointestinal issues were likely secondary. The more important problem was respiratory narrowing. He recommended a short course of steroids, which I obtained from a local clinic.

The improvement was almost immediate.

My dog recovered.

But what stayed with me wasn't relief.

It was the realization that I had just experienced a textbook example of a market failure.

The Ultimate Credence Good

Economists classify products and services into three broad categories.

Search goods can be evaluated before purchase. A laptop's specifications, for example, are visible upfront.

Experience goods can be evaluated after consumption. A restaurant meal falls into this category.

Then there are credence goods—products and services whose quality remains difficult to assess even after you've consumed them.

Healthcare is the classic example.

Veterinary care is arguably even worse.

When humans visit a doctor, patients can describe symptoms, explain side effects, and report whether treatment is working. In veterinary medicine, the buyer and the patient are different entities.

The consumer is the dog.

The customer is the owner.

The patient cannot explain what hurts.

The owner cannot independently verify the diagnosis.

Even after treatment succeeds, it is often impossible to know whether the diagnosis was correct, whether the tests were necessary, or whether a cheaper alternative would have worked just as well.

This creates extreme information asymmetry.

The veterinarian possesses nearly all the information.

The customer possesses almost none.

Markets generally function best when buyers can compare quality and price. Veterinary medicine operates under conditions where both are difficult to observe.

Why Expertise Matters More Than Equipment

Most pet owners assume that veterinary quality comes from facilities, equipment, or branding.

My experience suggests otherwise.

The critical variable is often the veterinarian's accumulated experience.

A highly experienced vet is essentially a pattern-recognition engine.

A veterinarian serving a massive market like China may encounter far more unusual cases than a local practitioner. Higher case volume accelerates learning. More cases mean better pattern recognition. Better pattern recognition means fewer unnecessary tests and faster diagnoses.

This does not mean local veterinarians are less capable.

In fact, many are working under significant uncertainty and following appropriate clinical protocols.

The problem is structural.

When a doctor has seen a condition ten times, they naturally behave differently from a doctor who has seen it a thousand times.

The difference isn't intelligence.

It's exposure.

And exposure compounds.

Why Pet Insurance Doesn't Solve the Problem

At first glance, pet insurance appears to be the solution.

I thought so too.

I hold a policy with NTUC Income.

After spending $1,500, I assumed I would at least recover part of the cost.

I was wrong.

The policy covered surgeries and hospitalizations.

It excluded virtually all outpatient treatment.

Insurance works best when claims are large, infrequent, and objectively verifiable.

A broken bone qualifies.

A major surgery qualifies.

A persistent cough does not.

The moment insurers start reimbursing routine outpatient diagnostics, they face two problems simultaneously.

The first is moral hazard.

Pet owners become less sensitive to cost because someone else is paying.

The second is verification difficulty.

Unlike a surgery, there is often no objective way to determine whether a particular diagnostic test or treatment was necessary.

Insurers are therefore forced into an impossible position. They must either trust every clinical decision or build expensive review processes that may cost more than the claims themselves.

Most choose a simpler solution.

They avoid the outpatient market altogether.

As a result, pet insurance primarily functions as catastrophe insurance rather than healthcare insurance.

It protects owners from rare disasters.

It does very little to reduce the everyday uncertainty of diagnosis.

The Future of Pet Healthcare

My dog's cough eventually disappeared.

The bills stopped arriving.

Life returned to normal.

But the experience changed how I think about the industry.

For decades, innovation in pet care has focused on products—better food, better supplements, better insurance policies.

Those matter.

But they don't solve the fundamental problem.

The biggest challenge in pet healthcare is not treatment.

It is diagnosis.

And diagnosis is ultimately a function of expertise.

The future of the industry may belong to whoever can make expertise more accessible, more scalable, and more transparent.

Because when your pet is sick, what you are really buying is not medicine.

You are buying confidence that someone knows what is wrong.

Today, that confidence is expensive.

Tomorrow, technology may finally make it abundant.